Journal articles on the topic 'Bisphosphonate'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Bisphosphonate.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Bergner, R. "Bisphosphonattherapie bei renaler Osteopathie." Osteologie 17, no. 03 (2008): 154–58. http://dx.doi.org/10.1055/s-0037-1619862.
Full textAnghelescu, Doralina L., Varayini Pankayatselvan, Rosa Nguyen, Deborah Ward, Jianrong Wu, Huiyun Wu, Denaya D. Edwards, and Wayne Furman. "Bisphosphonate Use in Pediatric Oncology for Pain Management." American Journal of Hospice and Palliative Medicine® 36, no. 2 (August 16, 2018): 138–42. http://dx.doi.org/10.1177/1049909118793114.
Full textKlotz, Christopher, Franz Jakob, Matthias Kohl, Simon von Stengel, Uwe Lange, Friederike Thomasius, Katharina Kerschan-Schindl, Michael Uder, and Wolfgang Kemmler. "Effekt von additivem körperlichem Training zur Bisphosphonat-Therapie auf die Knochendichte: Eine systematische Übersichtsarbeit und Meta-Analyse." Osteologie 31, no. 03 (August 2022): 184–94. http://dx.doi.org/10.1055/a-1904-5706.
Full textStepaniuk, Kevin. "Bisphosphonate Related Osteonecrosis of the Jaws: A Review." Journal of Veterinary Dentistry 28, no. 4 (December 2011): 277–81. http://dx.doi.org/10.1177/089875641102800413.
Full textThirunavukarasu, Ananthi, Hugo Grancho Pinto, and Kevin Guy Seymour. "Bisphosphonate and Implant Dentistry – is it Safe?" Primary Dental Journal 4, no. 3 (September 2015): 30–33. http://dx.doi.org/10.1308/205016815815944650.
Full textKawai, Toshiyuki, Kohei Nishitani, Yaichiro Okuzu, Koji Goto, Yutaka Kuroda, Shinichi Kuriyama, Shinichiro Nakamura, and Shuichi Matsuda. "Bisphosphonate use is associated with a decreased joint narrowing rate in the non-arthritic hip." Bone & Joint Research 11, no. 11 (November 1, 2022): 826–34. http://dx.doi.org/10.1302/2046-3758.1111.bjr-2022-0155.r1.
Full textBourrion, Bastien, Cécile Souty, Lucie Fournier, Ana-Maria Vilcu, Thierry Blanchon, Pierre-Yves Böelle, Thomas Hanslik, and Mathilde François. "Bisphosphonate Use and Hospitalization for Hip Fractures in Women: An Observational Population-Based Study in France." International Journal of Environmental Research and Public Health 18, no. 16 (August 20, 2021): 8780. http://dx.doi.org/10.3390/ijerph18168780.
Full textLloyd, Ashley A., Bernd Gludovatz, Christoph Riedel, Emma A. Luengo, Rehan Saiyed, Eric Marty, Dean G. Lorich, et al. "Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance." Proceedings of the National Academy of Sciences 114, no. 33 (July 31, 2017): 8722–27. http://dx.doi.org/10.1073/pnas.1704460114.
Full textNtep, Ntep David Bienvenue, Ernest Kenna, Siafa Antoine Bola, and Messanga Charles Bengondo. "The Potential Role of Angiogenic Osteoclast Inhibition in the Occurrence of Bisphosphonate-related Osteonecrosis of the Jaw." Case Reports in Dental Science 1, no. 1 (June 30, 2020): 15–21. http://dx.doi.org/10.46619/crds.2020.1-1004.
Full textSawatari, Yoh, and Robert E. Marx. "Bisphosphonates and Bisphosphonate Induced Osteonecrosis." Oral and Maxillofacial Surgery Clinics of North America 19, no. 4 (November 2007): 487–98. http://dx.doi.org/10.1016/j.coms.2007.07.003.
Full textPaskins, Zoe, Fay Crawford-Manning, Elizabeth Cottrell, Nadia Corp, Jenny Wright, Clare Jinks, Simon Bishop, et al. "Acceptability of bisphosphonates among patients, clinicians and managers: a systematic review and framework synthesis." BMJ Open 10, no. 11 (November 2020): e040634. http://dx.doi.org/10.1136/bmjopen-2020-040634.
Full textNeogi, Tuhina, Shanshan Li, Christine Peloquin, Devyani Misra, and Yuqing Zhang. "Effect of bisphosphonates on knee replacement surgery." Annals of the Rheumatic Diseases 77, no. 1 (October 7, 2017): 92–97. http://dx.doi.org/10.1136/annrheumdis-2017-211811.
Full textI, Bashir. "Bisphosphonates in Postmenopausal Women with Osteoporosis to Prevent Future Fractures." Journal of Orthopaedics & Bone Disorders 3, no. 2 (2019): 1–8. http://dx.doi.org/10.23880/jobd-16000179.
Full textChlebowski, Rowan T., Zhao Chen, Jane A. Cauley, Garnet Anderson, Rebecca J. Rodabough, Anne McTiernan, Dorothy S. Lane, et al. "Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women." Journal of Clinical Oncology 28, no. 22 (August 1, 2010): 3582–90. http://dx.doi.org/10.1200/jco.2010.28.2095.
Full textZhou, Jifang, Karen Sweiss, Edith A. Nutescu, Jin Han, Pritesh R. Patel, Naomi Y. Ko, Todd A. Lee, Brian C. H. Chiu, and Gregory S. Calip. "Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare." JCO Oncology Practice 17, no. 3 (March 2021): e294-e312. http://dx.doi.org/10.1200/op.20.00479.
Full textGnant, Michael, Catherine Van Poznak, and Lowell Schnipper. "Therapeutic Bone-Modifying Agents in the Nonmetastatic Breast Cancer Setting: The Controversy and a Value Assessment." American Society of Clinical Oncology Educational Book, no. 37 (May 2017): 116–22. http://dx.doi.org/10.1200/edbk_177357.
Full textBeck, V., E. Solomayer, M. Krimmel, C. Reinert, and T. Fehm. "Bisphosphonate-induced osteonecrosis of the jaw: Incidence and risk factors in patients with breast cancer and gynecological malignancies." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 1113. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.1113.
Full textOkçu, Mehmet, Fatmanur Aybala Koçak, Samet Sancar Kaya, and Figen Tuncay. "Is there a familial predisposition to bisphosphonate-induced atypical femoral fractures?" Turkish Journal of Physical Medicine and Rehabilitation 67, no. 3 (September 1, 2021): 370–73. http://dx.doi.org/10.5606/tftrd.2021.5248.
Full textSapkota, S., S. Baig, T. Hess, A. M. O’Connell, J. Menk, M. Shyne, P. Fazeli, K. Ensrud, and A. Shmagel. "Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?" Lupus 29, no. 3 (January 29, 2020): 263–72. http://dx.doi.org/10.1177/0961203320903086.
Full textMustafa, W., R. O'Byrne, B. Okpaje, A. Gabr, B. Ali, A. Mohamed, S. Cameron, et al. "233 BISPHOSPHONATES: ANOTHER COMPLEX DRUG TO PRESCRIBE." Age and Ageing 50, Supplement_3 (November 2021): ii9—ii41. http://dx.doi.org/10.1093/ageing/afab219.233.
Full textUtari, Tita Ratya, Muhammad Fariez Kurniawan, and Shylvia Muchsin Andewa. "<strong>The controlled release profile of risedronate emulgel to inhibit relapse movement in orthodontic treatment</strong>." Padjadjaran Journal of Dentistry 34, no. 1 (April 9, 2022): 66. http://dx.doi.org/10.24198/pjd.vol34no1.32628.
Full textAtaallah, Basma, Christina Nania, and Neel Shah. "PSAT188 Keeping An Eye On Bisphosphonates: Drug Induced Uveitis." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A205. http://dx.doi.org/10.1210/jendso/bvac150.421.
Full textLicata, Angelo A. "Discovery, Clinical Development, and Therapeutic Uses of Bisphosphonates." Annals of Pharmacotherapy 39, no. 4 (April 2005): 668–77. http://dx.doi.org/10.1345/aph.1e357.
Full textGuthrie, Ariane, Kathleen Fairman, and Dawn Knudsen Gerber. "Fractured Timelines: Reporting Patterns for Bisphosphonate-Associated Atypical Fractures and Implications for Postmarket Surveillance." Senior Care Pharmacist 37, no. 11 (November 1, 2022): 555–64. http://dx.doi.org/10.4140/tcp.n.2022.555.
Full textWilkinson, Gregg S., Jacques Baillargeon, Yong-Fang Kuo, Jean L. Freeman, and James S. Goodwin. "Atrial Fibrillation and Stroke Associated With Intravenous Bisphosphonate Therapy in Older Patients With Cancer." Journal of Clinical Oncology 28, no. 33 (November 20, 2010): 4898–905. http://dx.doi.org/10.1200/jco.2010.28.7524.
Full textShalev, Varda, Sarah Sharman Moser, Inbal Goldshtein, Jingbo Yu, Clara Weil, Sophia Ish-Shalom, Vanessa Rouach, and Gabriel Chodick. "Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data." Annals of Pharmacotherapy 51, no. 9 (May 23, 2017): 757–67. http://dx.doi.org/10.1177/1060028017710482.
Full textIto, Kouta, Victoria S. Blinder, and Elena B. Elkin. "Cost Effectiveness of Fracture Prevention in Postmenopausal Women Who Receive Aromatase Inhibitors for Early Breast Cancer." Journal of Clinical Oncology 30, no. 13 (May 1, 2012): 1468–75. http://dx.doi.org/10.1200/jco.2011.38.7001.
Full textHayes, Kaleen N., Elizabeth M. Winter, Suzanne M. Cadarette, and Andrea M. Burden. "Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making." Journal of Clinical Medicine 10, no. 5 (March 9, 2021): 1140. http://dx.doi.org/10.3390/jcm10051140.
Full textWasserzug, Oshri, Israel Kaffe, Towy Sorel Lazarovici, Tal Weissman, Ran Yahalom, Dan M. Fliss, and Noam Yarom. "Involvement of the Maxillary Sinus in Bisphosphonate-Related Osteonecrosis of the Jaw: Radiologic Aspects." American Journal of Rhinology & Allergy 31, no. 1 (January 2017): 36–39. http://dx.doi.org/10.2500/ajra.2017.31.4395.
Full textArponen, Heidi, Ilkka Vuorimies, Jari Haukka, Helena Valta, Janna Waltimo-Sirén, and Outi Mäkitie. "Cranial base pathology in pediatric osteogenesis imperfecta patients treated with bisphosphonates." Journal of Neurosurgery: Pediatrics 15, no. 3 (March 2015): 313–20. http://dx.doi.org/10.3171/2014.11.peds14113.
Full textVassaki, Maria, Konstantinos E. Papathanasiou, Chrystalleni Hadjicharalambous, Daphne Chandrinou, Petri Turhanen, Duane Choquesillo-Lazarte, and Konstantinos D. Demadis. "Self-sacrificial MOFs for ultra-long controlled release of bisphosphonate anti-osteoporotic drugs." Chemical Communications 56, no. 38 (2020): 5166–69. http://dx.doi.org/10.1039/d0cc00439a.
Full textPorta-Sales, Josep, Cristina Garzón-Rodríguez, Silvia Llorens-Torromé, Cinzia Brunelli, Alessandra Pigni, and Augusto Caraceni. "Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project." Palliative Medicine 31, no. 1 (July 10, 2016): 5–25. http://dx.doi.org/10.1177/0269216316639793.
Full textGovindarajan, Vaidya, Anthony Diaz, Roberto J. Perez-Roman, S. Shelby Burks, Michael Y. Wang, and Allan D. Levi. "Osteoporosis treatment in patients undergoing spinal fusion: a systematic review and meta-analysis." Neurosurgical Focus 50, no. 6 (June 2021): E9. http://dx.doi.org/10.3171/2021.3.focus2175.
Full textCoskun Benlidayi, Ilke, and Rengin Guzel. "Oral Bisphosphonate Related Osteonecrosis of the Jaw: A Challenging Adverse Effect." ISRN Rheumatology 2013 (May 16, 2013): 1–6. http://dx.doi.org/10.1155/2013/215034.
Full textKim, Hyung Joon, Ha Jin Kim, YunJeong Choi, Moon-Kyoung Bae, Dae Seok Hwang, Sang-Hun Shin, and Jae-Yeol Lee. "Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis." International Journal of Molecular Sciences 20, no. 6 (March 22, 2019): 1467. http://dx.doi.org/10.3390/ijms20061467.
Full textPramanik, Chandrani, Tianda Wang, Sushanta Ghoshal, Lina Niu, Bradley A. Newcomb, Yaodong Liu, Carolyn M. Primus, et al. "Microfibrous borate bioactive glass dressing sequesters bone-bound bisphosphonate in the presence of simulated body fluid." Journal of Materials Chemistry B 3, no. 6 (2015): 959–63. http://dx.doi.org/10.1039/c4tb02035a.
Full textNanki, Toshihiro, Mai Kawazoe, Kiyoko Uno, Wataru Hirose, Hiroaki Dobashi, Hiroshi Kataoka, Toshihide Mimura, Hiroshi Hagino, and Hajime Kono. "Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial." Journal of Clinical Medicine 12, no. 1 (December 30, 2022): 292. http://dx.doi.org/10.3390/jcm12010292.
Full textRuggiero, Salvatore, Julie Gralow, Robert E. Marx, Ana O. Hoff, Mark M. Schubert, Joseph M. Huryn, Bela Toth, Kathryn Damato, and Vicente Valero. "Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer." Journal of Oncology Practice 2, no. 1 (January 2006): 7–14. http://dx.doi.org/10.1200/jop.2006.2.1.7.
Full textSchöffel, D. "Wirkung von Bisphophonaten auf Osteoporoseschmerzen." Osteologie 17, no. 04 (2008): 219–21. http://dx.doi.org/10.1055/s-0037-1619870.
Full textWalia, Manpreet S., Saryu Arora, and Bhawana Singal. "Jaw Osteonecrosis a Risk Factor in Bisphosphonate Therapy - A Dental Concern." Journal of Oral Health and Community Dentistry 4, no. 3 (2010): 72–77. http://dx.doi.org/10.5005/johcd-4-3-72.
Full textErdem, Yusuf, Zafer Atbasi, Tuluhan Yunus Emre, Gülis Kavadar, and Bahtiyar Demiralp. "Effect of Long-Term Use of Bisphosphonates on Forearm Bone: Atypical Ulna Fractures in Elderly Woman with Osteoporosis." Case Reports in Orthopedics 2016 (2016): 1–4. http://dx.doi.org/10.1155/2016/4185202.
Full textOteri, Giacomo, Ennio Bramanti, Valentina Nigrone, and Marco Cicciù. "Decayed, Missing, and Filled Teeth Index and Periodontal Health in Osteoporotic Patients Affected by BRONJ: An Observational Study." Journal of Osteoporosis 2013 (2013): 1–7. http://dx.doi.org/10.1155/2013/231289.
Full textNewcomb, Polly A., Michael N. Passarelli, Amanda I. Phipps, Garnet L. Anderson, Jean Wactawski-Wende, Gloria Y. F. Ho, Mary Jo O'Sullivan, and Rowan T. Chlebowski. "Oral Bisphosphonate Use and Risk of Postmenopausal Endometrial Cancer." Journal of Clinical Oncology 33, no. 10 (April 1, 2015): 1186–90. http://dx.doi.org/10.1200/jco.2014.58.6842.
Full textFAVIA, GIANFRANCO, GIOVANNI PIETRO PILOLLI, and EUGENIO MAIORANO. "Osteonecrosis of the Jaw Correlated to Bisphosphonate Therapy in Non-oncologic Patients: Clinicopathological Features of 24 Patients." Journal of Rheumatology 36, no. 12 (November 2, 2009): 2780–87. http://dx.doi.org/10.3899/jrheum.090455.
Full textKirpichnikov, M. V., V. V. Podolsky, E. N. Yarygina, A. S. Serbin, and K. A. Aleshanov. "Care and management of bisphosphonate-associated osteonecrosis of jaw in patient with pathological fracture of mandible: case study." Medical alphabet 3, no. 23 (November 21, 2019): 34–36. http://dx.doi.org/10.33667/2078-5631-2019-3-23(398)-34-36.
Full textEbzeev, A. K. "Bisphosphonate-related osteonecrosis of the jaw (BRONJ) in cancer patients." Kazan medical journal 101, no. 2 (April 13, 2020): 226–31. http://dx.doi.org/10.17816/kmj2020-226.
Full textWellman, Samuel S., David E. Attarian, and Jordan F. Schaeffer. "Periprosthetic Femoral Insufficiency Fracture in a Patient on Long-term Bisphosphonate Therapy." Duke Orthopaedic Journal 2, no. 1 (2012): 66–69. http://dx.doi.org/10.5005/jp-journals-10017-1021.
Full textAlQarooni, Sayed Hashim, Ugo Ruggiero, and Sri Priya Suresh. "Atypical fractures secondary to bisphosphonate therapy: A case series and pictorial review." Indian Journal of Musculoskeletal Radiology 3 (June 30, 2021): 45–53. http://dx.doi.org/10.25259/ijmsr_2_2021.
Full textYang, Yan-Li, Zi-Jian Xiang, Jing-Hua Yang, Wen-Jie Wang, and Ruo-Lan Xiang. "The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis." Therapeutic Advances in Medical Oncology 11 (January 2019): 175883591985523. http://dx.doi.org/10.1177/1758835919855235.
Full textStevenson, Matt D., Jeremy E. Oakley, Myfawny Lloyd Jones, Alan Brennan, Juliet E. Compston, Eugene V. McCloskey, and Peter L. Selby. "The Cost-Effectiveness of an RCT to Establish Whether 5 or 10 Years of Bisphosphonate Treatment Is the Better Duration for Women With a Prior Fracture." Medical Decision Making 29, no. 6 (June 9, 2009): 678–89. http://dx.doi.org/10.1177/0272989x09336077.
Full text